<DOC>
	<DOCNO>NCT00808743</DOCNO>
	<brief_summary>Duodenal carcinoma lead cause mortality patient Familial Adenomatous Polyposis ( FAP ) underwent prophylactic colorectal surgery . The purpose study determine wether celecoxib combine ursodeoxycholic acid effective chemoprevention strategy influence progression duodenal adenoma carcinoma patient FAP .</brief_summary>
	<brief_title>Prevention Progression Duodenal Adenomas Patients With Familial Adenomatous Polyposis</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Adenomatous Polyposis Coli</mesh_term>
	<mesh_term>Duodenal Neoplasms</mesh_term>
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<criteria>Patients Familial adenomatous Polyposis : APCmutation identify 100 colorectal polyp diagnosis Spigelman score duodenal adenoma equal II III Incapability signing inform consent Active gastric duodenal ulcer , gastrointestinal bleeding Cardiovascular disease risk : Congestive cardiac failure : NYHA class II IV Proven ischemic heart disease and/or cerebrovascular disease Risk factor : hypertension , hyperlipidaemia , diabetes mellitus , family history cardiovascular event ( â‰¥2 first degree family member &lt; 55 year ) Renal dysfunction : creatinine clearance 50mL/min Liver dysfunction : albumin 25 g/L ChildPughscore equal 10 Known allergic reaction sulfonamide , NSAIDs ursodeoxycholic acid Use NSAIDs ursodeoxycholic acid 1 week 6 month prior start study Use lithium Symptomatic gallstone Inflammatory bowel disease ( Possible ) pregnancy breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Familial adenomatous polyposis</keyword>
	<keyword>Adenomatous Polyposis Coli</keyword>
	<keyword>Digestive System Neoplasms</keyword>
	<keyword>Gastrointestinal Disease</keyword>
	<keyword>Intestinal disease</keyword>
	<keyword>Intestinal neoplasm</keyword>
	<keyword>Gastrointestinal neoplasm</keyword>
	<keyword>Polyps</keyword>
	<keyword>Adenoma</keyword>
	<keyword>Adenomatous Polyps</keyword>
	<keyword>Neoplastic Syndromes , Hereditary</keyword>
	<keyword>Digestive System Diseases</keyword>
	<keyword>Genetic Diseases , Inborn</keyword>
	<keyword>Chemoprevention</keyword>
	<keyword>Celecoxib</keyword>
	<keyword>Ursodeoxycholic acid</keyword>
	<keyword>Anti-Inflammatory agent , Non-Steroidal</keyword>
	<keyword>Cyclooxygenase Inhibitors</keyword>
</DOC>